Jacobs Levy Equity Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-78,515
Closed -$730K 1008
2023
Q4
$730K Sell
78,515
-102,418
-57% -$1.06M ﹤0.01% 775
2023
Q3
$2.3M Sell
180,933
-20,334
-10% -$279K 0.01% 538
2023
Q2
$2.86M Buy
201,267
+43,626
+28% +$613K 0.02% 505
2023
Q1
$2.35M Buy
+157,641
New +$2.39M 0.01% 543
2020
Q2
Sell
-324,084
Closed -$3.77M 1111
2020
Q1
$3.77M Buy
+324,084
New +$6.68M 0.05% 350
2019
Q2
Sell
-104,582
Closed -$2.84M 993
2019
Q1
$2.84M Buy
104,582
+34,300
+49% +$1.15M 0.04% 444
2018
Q4
$2.32M Buy
+70,282
New +$2.83M 0.04% 430
2015
Q4
Sell
-5,700
Closed -$438K 855
2015
Q3
$438K Hold
5,700
0.01% 594
2015
Q2
$422K Sell
5,700
-6,300
-53% -$453K 0.01% 597
2015
Q1
$870K Sell
12,000
-1,700
-12% -$118K 0.01% 504
2014
Q4
$906K Sell
13,700
-20,300
-60% -$1.24M 0.02% 524
2014
Q3
$1.86M Buy
+34,000
New +$1.93M 0.03% 397
2014
Q1
Sell
-9,500
Closed -$507K 959
2013
Q4
$507K Buy
+9,500
New +$510K 0.01% 714

Other funds holding MD

Jacobs Levy Equity Management's MD Position: Q1 2024 in Review

Jacobs Levy Equity Management sold out of Pediatrix Medical (MD) in Q1 2024, closing a stake of 78,515 shares — an estimated $730K sold.

Jacobs Levy Equity Management first reported a position in MD in Q4 2013 and held it in 13 quarters. The position peaked at $3.77M in Q1 2020. 213 funds tracked by Wall St. Rank hold MD as of Q1 2024.

  • Jacobs Levy Equity Management reported no remaining Pediatrix Medical position as of Q1 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 78,515 Pediatrix Medical shares in Q1 2024, an estimated $730K.
  • Jacobs Levy Equity Management first reported a position in Pediatrix Medical in Q4 2013 and held it in 13 quarters.
  • Jacobs Levy Equity Management's Pediatrix Medical position peaked at $3.77M in Q1 2020.
  • 213 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2024, filed 15 May 2024.